Free Trial

BlueLinx (BXC) Financials

BlueLinx logo
$67.13 +0.34 (+0.51%)
As of 01:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for BlueLinx

Annual Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/28/2024 12/30/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders
53 49 296
Consolidated Net Income / (Loss)
53 49 296
Net Income / (Loss) Continuing Operations
53 49 296
Total Pre-Tax Income
71 82 395
Total Operating Income
88 138 439
Total Gross Profit
489 527 833
Total Revenue
2,953 3,136 4,450
Operating Revenue
2,953 3,136 4,450
Total Cost of Revenue
2,463 2,609 3,617
Operating Cost of Revenue
2,463 2,609 3,617
Total Operating Expenses
402 389 394
Selling, General & Admin Expense
367 360 370
Depreciation Expense
38 32 28
Other Operating Expenses / (Income)
-3.93 -3.93 -
Other Special Charges / (Income)
-0.27 0.00 -0.14
Total Other Income / (Expense), net
-17 -57 -44
Interest & Investment Income
-19 -24 -42
Other Income / (Expense), net
2.48 -33 -2.05
Income Tax Expense
18 33 99
Basic Earnings per Share
$6.22 $5.40 $31.75
Weighted Average Basic Shares Outstanding
8.29M 8.65M 9.06M
Diluted Earnings per Share
$6.19 $5.39 $31.51
Weighted Average Diluted Shares Outstanding
8.29M 8.65M 9.06M
Weighted Average Basic & Diluted Shares Outstanding
8.29M 8.65M 9.06M

Quarterly Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/30/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Net Income / (Loss) Attributable to Common Shareholders
2.81 5.27 16 14 17 -18 24 24 18 32 60
Consolidated Net Income / (Loss)
2.81 5.27 16 14 17 -18 24 24 18 32 60
Net Income / (Loss) Continuing Operations
2.81 5.27 16 14 17 -18 24 24 18 32 60
Total Pre-Tax Income
4.14 6.97 22 19 23 -8.02 33 32 24 41 81
Total Operating Income
11 12 24 24 28 27 40 39 33 51 91
Total Gross Profit
111 113 126 122 128 118 139 136 134 151 189
Total Revenue
709 711 747 768 726 713 810 816 798 848 1,061
Operating Revenue
709 711 747 768 726 713 810 816 798 848 1,061
Total Cost of Revenue
598 597 622 646 599 594 671 680 664 697 871
Operating Cost of Revenue
598 597 622 646 599 594 671 680 664 697 871
Total Operating Expenses
100 101 102 99 100 91 100 97 101 100 99
Selling, General & Admin Expense
94 93 93 89 92 84 92 90 94 93 93
Depreciation Expense
9.55 9.41 9.53 10 9.43 8.29 8.09 7.95 7.72 7.66 6.69
Other Operating Expenses / (Income)
-3.24 -0.98 -0.98 -0.98 -0.98 -0.98 -0.98 -0.98 -0.98 - -0.98
Total Other Income / (Expense), net
-6.58 -5.07 -2.39 -4.80 -4.62 -35 -6.17 -6.91 -8.28 -12 -10
Interest & Investment Income
-6.58 - -4.62 -4.80 - - -5.58 -6.31 - - -
Income Tax Expense
1.34 1.69 5.62 4.71 5.55 10 9.10 7.72 6.42 8.74 21
Basic Earnings per Share
$0.33 $0.67 $1.88 $1.65 $2.02 ($1.98) $2.72 $2.70 $1.96 $3.95 $6.44
Weighted Average Basic Shares Outstanding
8.02M 8.29M 8.38M 8.53M 8.66M 8.65M 8.77M 9.00M 9.09M 9.06M 9.04M
Diluted Earnings per Share
$0.33 $0.67 $1.87 $1.65 $2.00 ($1.96) $2.71 $2.70 $1.94 $4.46 $6.38
Weighted Average Diluted Shares Outstanding
8.02M 8.29M 8.38M 8.53M 8.66M 8.65M 8.77M 9.00M 9.09M 9.06M 9.04M
Weighted Average Basic & Diluted Shares Outstanding
8.02M 8.29M 8.38M 8.53M 8.66M 8.65M 8.77M 9.00M 9.09M 9.06M 9.04M

Annual Cash Flow Statements for BlueLinx

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/28/2024 12/30/2023 12/31/2022
Net Change in Cash & Equivalents
-16 223 214
Net Cash From Operating Activities
85 306 400
Net Cash From Continuing Operating Activities
85 306 400
Net Income / (Loss) Continuing Operations
53 49 296
Consolidated Net Income / (Loss)
53 49 296
Depreciation Expense
38 32 28
Amortization Expense
-2.62 -2.62 -2.78
Non-Cash Adjustments To Reconcile Net Income
7.48 42 9.47
Changes in Operating Assets and Liabilities, net
-11 187 70
Net Cash From Investing Activities
-39 -27 -99
Net Cash From Continuing Investing Activities
-39 -27 -99
Purchase of Property, Plant & Equipment
-40 -28 -36
Acquisitions
0.00 0.30 -64
Sale of Property, Plant & Equipment
0.90 0.36 0.96
Net Cash From Financing Activities
-62 -57 -88
Net Cash From Continuing Financing Activities
-62 -57 -88
Repurchase of Common Equity
-45 -42 -66
Other Financing Activities, net
-17 -14 -21
Cash Interest Paid
45 43 44
Cash Income Taxes Paid
30 19 111

Quarterly Cash Flow Statements for BlueLinx

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/30/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Net Change in Cash & Equivalents
-57 -21 35 10 -40 52 51 42 77 70 124
Net Cash From Operating Activities
-34 19 62 36 -31 76 78 64 89 154 143
Net Cash From Continuing Operating Activities
-34 19 62 36 -31 76 78 64 89 154 143
Net Income / (Loss) Continuing Operations
2.81 5.27 16 14 17 -18 24 24 18 32 60
Consolidated Net Income / (Loss)
2.81 5.27 16 14 17 -18 24 24 18 32 60
Depreciation Expense
9.55 9.41 9.53 10 9.43 8.29 8.09 7.95 7.72 7.66 6.69
Amortization Expense
-0.65 -0.65 -0.65 -0.65 -0.65 -0.65 -0.65 -0.65 -0.66 -0.65 -0.65
Non-Cash Adjustments To Reconcile Net Income
0.08 2.76 0.96 1.41 2.35 32 2.98 1.93 4.57 3.59 2.09
Changes in Operating Assets and Liabilities, net
-46 1.96 36 11 -60 54 43 30 60 112 75
Net Cash From Investing Activities
-3.39 -20 -7.36 -6.31 -5.32 -8.12 -4.84 -4.94 -8.97 -80 -12
Net Cash From Continuing Investing Activities
-3.39 -20 -7.36 -6.31 -5.32 -8.12 -4.84 -4.94 -8.97 -80 -12
Purchase of Property, Plant & Equipment
-5.93 -20 -7.93 -6.45 -5.45 -8.58 -4.90 -5.03 -9.01 -17 -12
Other Investing Activities, net
2.54 - - - - - - - - - -
Net Cash From Financing Activities
-19 -19 -20 -19 -3.98 -15 -21 -17 -2.70 -4.42 -6.11
Net Cash From Continuing Financing Activities
-19 -19 -20 -19 -3.98 -15 -21 -17 -2.70 -4.42 -6.11
Repurchase of Common Equity
-15 -15 -15 - - -13 -18 - - - -
Other Financing Activities, net
-4.30 -3.87 -4.06 -4.88 -3.98 -2.67 -3.59 -5.52 -2.70 -4.42 -6.11
Cash Interest Paid
7.16 16 6.88 15 6.80 15 6.48 15 6.19 19 2.12
Cash Income Taxes Paid
-1.08 6.18 2.13 21 1.34 1.56 6.86 11 0.00 21 29

Annual Balance Sheets for BlueLinx

This table presents BlueLinx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/28/2024 12/30/2023 12/31/2022
Total Assets
1,578 1,538 1,490
Total Current Assets
1,134 1,120 1,077
Cash & Equivalents
506 522 299
Accounts Receivable
226 228 252
Inventories, net
356 344 484
Other Current Assets
47 27 42
Plant, Property, & Equipment, net
250 226 206
Total Noncurrent Assets
194 191 208
Goodwill
55 55 55
Intangible Assets
27 31 35
Noncurrent Deferred & Refundable Income Taxes
51 53 56
Other Noncurrent Operating Assets
61 52 61
Total Liabilities & Shareholders' Equity
1,578 1,538 1,490
Total Liabilities
931 903 900
Total Current Liabilities
234 219 211
Accounts Payable
170 158 152
Current Deferred Revenue
3.94 3.94 3.94
Current Employee Benefit Liabilities
17 14 23
Other Current Liabilities
43 42 33
Total Noncurrent Liabilities
698 685 689
Long-Term Debt
295 294 292
Other Noncurrent Operating Liabilities
402 391 397
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
646 634 590
Total Preferred & Common Equity
646 634 590
Preferred Stock
0.00 0.00 0.00
Total Common Equity
646 634 590
Common Stock
124 165 201
Retained Earnings
522 469 421

Quarterly Balance Sheets for BlueLinx

This table presents BlueLinx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/29/2025 9/28/2024 6/29/2024 3/30/2024 9/30/2023 7/1/2023 4/1/2023 10/1/2022
Total Assets
1,633 1,611 1,586 1,592 1,585 1,550 1,526 1,534
Total Current Assets
1,166 1,181 1,159 1,173 1,171 1,137 1,114 1,158
Cash & Equivalents
449 526 491 481 470 418 376 229
Accounts Receivable
276 278 274 288 298 294 299 361
Inventories, net
400 341 358 371 364 379 409 536
Other Current Assets
42 37 36 32 40 45 29 32
Plant, Property, & Equipment, net
275 236 232 231 216 210 208 189
Plant, Property & Equipment, gross
462 424 414 407 382 374 366 340
Accumulated Depreciation
187 188 182 176 166 163 158 151
Total Noncurrent Assets
192 194 195 188 199 203 204 187
Goodwill
55 55 55 55 55 55 55 48
Intangible Assets
26 28 29 30 32 33 34 11
Noncurrent Deferred & Refundable Income Taxes
51 51 54 54 55 56 56 61
Other Noncurrent Operating Assets
60 59 57 49 57 59 59 66
Total Liabilities & Shareholders' Equity
1,633 1,611 1,586 1,592 1,585 1,550 1,526 1,534
Total Liabilities
997 955 934 938 954 928 915 976
Total Current Liabilities
281 258 237 249 268 245 228 273
Accounts Payable
213 186 179 172 202 190 177 208
Current Deferred Revenue
3.94 3.94 3.94 3.94 3.94 3.94 3.94 -
Current Employee Benefit Liabilities
14 18 12 14 21 16 15 18
Other Current Liabilities
50 49 42 60 41 34 32 40
Total Noncurrent Liabilities
717 698 696 689 686 683 687 703
Long-Term Debt
295 295 294 294 293 293 293 292
Other Noncurrent Operating Liabilities
421 403 402 395 393 390 394 330
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
636 656 652 653 632 623 611 558
Total Preferred & Common Equity
636 656 652 653 632 623 611 558
Preferred Stock
0.00 0.00 0.00 0.00 - - - -
Total Common Equity
636 656 652 653 632 623 611 558
Common Stock
111 139 151 167 175 191 204 198
Retained Earnings
525 517 501 487 487 463 438 389

Annual Metrics And Ratios for BlueLinx

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric 2024 2023 2022
Period end date 12/28/2024 12/30/2023 12/31/2022
Growth Metrics
- - -
Revenue Growth
-5.86% -29.52% 4.05%
EBITDA Growth
-6.77% -70.76% -0.69%
EBIT Growth
-14.75% -75.83% -0.53%
NOPAT Growth
-19.81% -75.09% 0.02%
Net Income Growth
9.44% -83.61% 0.01%
EPS Growth
14.84% -82.89% 5.07%
Operating Cash Flow Growth
-72.19% -23.49% 176.02%
Free Cash Flow Firm Growth
-86.04% -17.75% 122.79%
Invested Capital Growth
7.28% -30.37% 2.49%
Revenue Q/Q Growth
-0.06% -4.13% -2.74%
EBITDA Q/Q Growth
15.88% -29.37% -11.47%
EBIT Q/Q Growth
21.83% -34.96% -12.29%
NOPAT Q/Q Growth
20.05% -33.09% -11.43%
Net Income Q/Q Growth
78.72% -50.80% -12.32%
EPS Q/Q Growth
73.88% -54.36% -8.43%
Operating Cash Flow Q/Q Growth
-40.01% -20.44% 51.51%
Free Cash Flow Firm Q/Q Growth
-57.85% -27.83% 22.70%
Invested Capital Q/Q Growth
2.79% -10.73% -15.65%
Profitability Metrics
- - -
Gross Margin
16.57% 16.80% 18.72%
EBITDA Margin
4.26% 4.31% 10.38%
Operating Margin
2.97% 4.41% 9.87%
EBIT Margin
3.05% 3.37% 9.82%
Profit (Net Income) Margin
1.80% 1.55% 6.66%
Tax Burden Percent
75.14% 59.27% 75.03%
Interest Burden Percent
78.50% 77.52% 90.33%
Effective Tax Rate
24.86% 40.73% 24.97%
Return on Invested Capital (ROIC)
15.63% 16.58% 57.15%
ROIC Less NNEP Spread (ROIC-NNEP)
21.41% 45.17% 23.82%
Return on Net Nonoperating Assets (RNNOA)
-7.33% -8.65% 4.99%
Return on Equity (ROE)
8.29% 7.93% 62.14%
Cash Return on Invested Capital (CROIC)
8.60% 52.39% 54.69%
Operating Return on Assets (OROA)
5.78% 6.98% 31.13%
Return on Assets (ROA)
3.41% 3.21% 21.10%
Return on Common Equity (ROCE)
8.29% 7.93% 62.14%
Return on Equity Simple (ROE_SIMPLE)
8.22% 7.65% 50.20%
Net Operating Profit after Tax (NOPAT)
66 82 329
NOPAT Margin
2.23% 2.62% 7.40%
Net Nonoperating Expense Percent (NNEP)
-5.79% -28.59% 33.33%
Return On Investment Capital (ROIC_SIMPLE)
6.99% 8.84% 37.33%
Cost of Revenue to Revenue
83.43% 83.20% 81.28%
SG&A Expenses to Revenue
12.44% 11.49% 8.32%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
13.60% 12.39% 8.85%
Earnings before Interest and Taxes (EBIT)
90 106 437
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
126 135 462
Valuation Ratios
- - -
Price to Book Value (P/BV)
1.34 1.57 1.09
Price to Tangible Book Value (P/TBV)
1.54 1.81 1.29
Price to Revenue (P/Rev)
0.29 0.32 0.14
Price to Earnings (P/E)
16.37 20.47 2.17
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
6.11% 4.89% 46.10%
Enterprise Value to Invested Capital (EV/IC)
1.51 1.88 1.09
Enterprise Value to Revenue (EV/Rev)
0.22 0.24 0.14
Enterprise Value to EBITDA (EV/EBITDA)
5.23 5.67 1.38
Enterprise Value to EBIT (EV/EBIT)
7.31 7.25 1.46
Enterprise Value to NOPAT (EV/NOPAT)
10.01 9.33 1.93
Enterprise Value to Operating Cash Flow (EV/OCF)
7.73 2.50 1.59
Enterprise Value to Free Cash Flow (EV/FCFF)
18.19 2.95 2.02
Leverage & Solvency
- - -
Debt to Equity
0.46 0.46 0.50
Long-Term Debt to Equity
0.46 0.46 0.50
Financial Leverage
-0.34 -0.19 0.21
Leverage Ratio
2.43 2.47 2.95
Compound Leverage Factor
1.91 1.92 2.66
Debt to Total Capital
31.34% 31.65% 33.14%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
31.34% 31.65% 33.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
68.66% 68.35% 66.86%
Debt to EBITDA
2.34 2.17 0.63
Net Debt to EBITDA
-1.67 -1.69 -0.01
Long-Term Debt to EBITDA
2.34 2.17 0.63
Debt to NOPAT
4.48 3.58 0.89
Net Debt to NOPAT
-3.20 -2.78 -0.02
Long-Term Debt to NOPAT
4.48 3.58 0.89
Altman Z-Score
3.77 4.06 5.48
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
4.85 5.13 5.11
Quick Ratio
3.13 3.43 2.61
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
36 259 315
Operating Cash Flow to CapEx
217.24% 1,127.58% 1,146.26%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
1.90 2.07 3.17
Accounts Receivable Turnover
13.00 13.07 15.06
Inventory Turnover
7.04 6.30 7.44
Fixed Asset Turnover
12.42 14.53 0.00
Accounts Payable Turnover
15.01 16.86 21.82
Days Sales Outstanding (DSO)
28.08 27.93 24.24
Days Inventory Outstanding (DIO)
51.83 57.91 49.08
Days Payable Outstanding (DPO)
24.31 21.65 16.73
Cash Conversion Cycle (CCC)
55.59 64.18 56.59
Capital & Investment Metrics
- - -
Invested Capital
436 406 584
Invested Capital Turnover
7.01 6.34 7.72
Increase / (Decrease) in Invested Capital
30 -177 14
Enterprise Value (EV)
659 765 636
Market Capitalization
869 993 643
Book Value per Share
$77.13 $72.35 $65.30
Tangible Book Value per Share
$67.32 $62.52 $55.30
Total Capital
942 928 882
Total Debt
295 294 292
Total Long-Term Debt
295 294 292
Net Debt
-211 -228 -6.52
Capital Expenditures (CapEx)
39 27 35
Debt-free, Cash-free Net Working Capital (DFCFNWC)
395 380 567
Debt-free Net Working Capital (DFNWC)
900 902 866
Net Working Capital (NWC)
900 902 866
Net Nonoperating Expense (NNE)
13 34 33
Net Nonoperating Obligations (NNO)
-211 -228 -6.52
Total Depreciation and Amortization (D&A)
36 29 25
Debt-free, Cash-free Net Working Capital to Revenue
13.37% 12.12% 12.75%
Debt-free Net Working Capital to Revenue
30.49% 28.75% 19.47%
Net Working Capital to Revenue
30.49% 28.75% 19.47%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$6.22 $5.40 $31.75
Adjusted Weighted Average Basic Shares Outstanding
8.29M 8.65M 9.06M
Adjusted Diluted Earnings per Share
$6.19 $5.39 $31.51
Adjusted Weighted Average Diluted Shares Outstanding
8.29M 8.65M 9.06M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
8.29M 8.65M 9.06M
Normalized Net Operating Profit after Tax (NOPAT)
66 82 329
Normalized NOPAT Margin
2.22% 2.62% 7.40%
Pre Tax Income Margin
2.39% 2.61% 8.87%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
85.28% 86.81% 22.43%

Quarterly Metrics And Ratios for BlueLinx

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/30/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.34% -0.27% -7.74% -5.83% -8.98% -15.95% -23.64% -34.16% -38.73% -12.87% 9.26%
EBITDA Growth
-46.15% 456.07% -24.45% -27.26% -6.51% -93.49% -52.13% -58.25% -80.43% -49.83% 24.24%
EBIT Growth
-61.24% 419.09% -32.80% -38.06% -13.32% -107.53% -57.12% -62.95% -83.47% -53.63% 26.96%
NOPAT Growth
-65.44% -52.15% -38.40% -39.59% -12.12% -52.63% -56.87% -62.87% -83.24% -51.29% 26.65%
Net Income Growth
-83.96% 129.09% -34.31% -41.40% -1.80% -156.66% -59.03% -65.67% -86.65% -56.55% 26.08%
EPS Growth
-83.50% 134.18% -31.00% -38.89% 3.09% -143.95% -57.52% -63.90% -85.29% -39.40% 34.60%
Operating Cash Flow Growth
-8.91% -75.19% -20.41% -44.19% -135.00% -51.02% -45.58% -36.60% 3,876.98% 749.27% 36.78%
Free Cash Flow Firm Growth
-111.23% -110.44% -81.59% -79.34% -60.04% 655.55% 652.09% 665.52% 1,906.97% 124.65% 54.65%
Invested Capital Growth
3.54% 7.28% -6.83% -8.48% -11.62% -30.37% -34.21% -34.44% -25.66% 2.49% 19.95%
Revenue Q/Q Growth
-0.20% -4.90% -2.74% 5.80% 1.92% -12.03% -0.73% 2.26% -5.88% -20.08% -14.41%
EBITDA Q/Q Growth
-6.70% -40.11% 5.45% -8.60% 863.44% -91.86% 1.53% 17.47% -32.96% -40.12% -11.45%
EBIT Q/Q Growth
-12.71% -53.20% 10.08% -13.81% 818.65% -109.86% 1.46% 20.61% -37.59% -43.85% -12.34%
NOPAT Q/Q Growth
-20.28% -48.81% -0.90% -14.53% 10.37% -34.10% -2.82% 24.34% -40.50% -40.00% -16.35%
Net Income Q/Q Growth
-46.79% -67.08% 11.72% -18.04% 196.51% -174.33% -0.34% 37.36% -44.31% -46.25% -16.50%
EPS Q/Q Growth
-50.75% -64.17% 13.33% -17.50% 202.04% -172.32% 0.37% 39.18% -56.50% -30.09% -14.71%
Operating Cash Flow Q/Q Growth
-280.90% -69.65% 72.52% 214.99% -141.21% -2.64% 20.97% -27.89% -42.33% 8.17% 40.92%
Free Cash Flow Firm Q/Q Growth
54.89% -141.91% -18.70% -26.92% -58.07% -26.09% -8.76% 41.34% 692.69% 154.01% 6.54%
Invested Capital Q/Q Growth
10.69% 2.79% -6.87% -2.28% 14.69% -10.73% -8.52% -5.64% -9.64% -15.65% -8.84%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
15.67% 15.95% 16.82% 15.94% 17.58% 16.62% 17.19% 16.64% 16.74% 17.83% 17.85%
EBITDA Margin
2.77% 2.96% 4.70% 4.34% 5.02% 0.53% 5.74% 5.61% 4.89% 6.86% 9.16%
Operating Margin
1.51% 1.69% 3.22% 3.10% 3.81% 3.82% 4.90% 4.79% 4.08% 6.03% 8.55%
EBIT Margin
1.51% 1.73% 3.51% 3.10% 3.81% -0.54% 4.82% 4.72% 4.00% 6.03% 8.59%
Profit (Net Income) Margin
0.40% 0.74% 2.14% 1.87% 2.41% -2.54% 3.01% 3.00% 2.23% 3.77% 5.61%
Tax Burden Percent
67.69% 75.69% 74.04% 75.27% 75.91% 225.96% 72.81% 76.01% 73.50% 78.54% 73.79%
Interest Burden Percent
38.64% 56.70% 82.40% 79.87% 83.29% 208.34% 85.72% 83.61% 75.92% 79.63% 88.53%
Effective Tax Rate
32.31% 24.31% 25.96% 24.73% 24.09% 0.00% 27.19% 23.99% 26.50% 21.46% 26.21%
Return on Invested Capital (ROIC)
6.34% 8.98% 16.00% 14.79% 17.85% 16.93% 20.34% 20.42% 19.12% 36.58% 45.53%
ROIC Less NNEP Spread (ROIC-NNEP)
8.95% 10.73% 16.87% 17.04% 20.44% 48.61% 41.59% 12.58% 10.00% 28.38% 42.06%
Return on Net Nonoperating Assets (RNNOA)
-2.37% -3.68% -5.35% -4.31% -4.38% -9.31% -1.48% 1.50% 1.21% 5.94% 21.46%
Return on Equity (ROE)
3.97% 5.31% 10.65% 10.49% 13.47% 7.61% 18.86% 21.92% 20.33% 42.52% 66.99%
Cash Return on Invested Capital (CROIC)
7.57% 8.60% 19.54% 22.86% 28.41% 52.39% 62.65% 67.17% 63.57% 54.69% 40.51%
Operating Return on Assets (OROA)
2.75% 3.28% 6.49% 5.97% 7.49% -1.12% 10.12% 10.86% 10.32% 19.13% 28.72%
Return on Assets (ROA)
0.72% 1.41% 3.96% 3.59% 4.74% -5.27% 6.31% 6.90% 5.76% 11.96% 18.76%
Return on Common Equity (ROCE)
3.97% 5.31% 10.65% 10.49% 13.47% 7.61% 18.86% 21.92% 20.33% 42.52% 66.99%
Return on Equity Simple (ROE_SIMPLE)
6.04% 0.00% 4.53% 5.84% 7.38% 0.00% 15.62% 21.48% 29.57% 0.00% 60.57%
Net Operating Profit after Tax (NOPAT)
7.26 9.11 18 18 21 19 29 30 24 40 67
NOPAT Margin
1.02% 1.28% 2.38% 2.34% 2.89% 2.67% 3.56% 3.64% 3.00% 4.74% 6.31%
Net Nonoperating Expense Percent (NNEP)
-2.61% -1.75% -0.87% -2.24% -2.59% -31.68% -21.25% 7.84% 9.11% 8.20% 3.47%
Return On Investment Capital (ROIC_SIMPLE)
0.78% 0.97% - - - 2.05% - - - 4.55% -
Cost of Revenue to Revenue
84.33% 84.05% 83.18% 84.06% 82.42% 83.38% 82.81% 83.36% 83.26% 82.17% 82.15%
SG&A Expenses to Revenue
13.27% 13.11% 12.46% 11.64% 12.61% 11.78% 11.42% 11.00% 11.82% 11.01% 8.76%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
14.16% 14.26% 13.60% 12.83% 13.77% 12.81% 12.30% 11.85% 12.66% 11.80% 9.30%
Earnings before Interest and Taxes (EBIT)
11 12 26 24 28 -3.85 39 38 32 51 91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
20 21 35 33 36 3.78 46 46 39 58 97
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.00 1.34 1.36 1.24 1.75 1.57 1.17 1.37 1.01 1.09 1.03
Price to Tangible Book Value (P/TBV)
1.15 1.54 1.56 1.42 2.01 1.81 1.36 1.59 1.18 1.29 1.16
Price to Revenue (P/Rev)
0.22 0.29 0.30 0.27 0.37 0.32 0.23 0.24 0.16 0.14 0.13
Price to Earnings (P/E)
16.54 16.37 29.99 21.17 23.68 20.47 7.49 6.37 3.41 2.17 1.71
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
6.05% 6.11% 3.33% 4.72% 4.22% 4.89% 13.35% 15.69% 29.33% 46.10% 58.60%
Enterprise Value to Invested Capital (EV/IC)
1.00 1.51 1.56 1.34 2.05 1.88 1.24 1.46 1.01 1.09 1.03
Enterprise Value to Revenue (EV/Rev)
0.16 0.22 0.22 0.20 0.31 0.24 0.17 0.21 0.13 0.14 0.16
Enterprise Value to EBITDA (EV/EBITDA)
4.52 5.23 6.07 5.08 7.20 5.67 2.94 3.02 1.75 1.38 1.36
Enterprise Value to EBIT (EV/EBIT)
6.82 7.31 8.93 7.03 9.42 7.25 3.46 3.41 1.91 1.46 1.43
Enterprise Value to NOPAT (EV/NOPAT)
9.19 10.01 12.04 9.13 11.96 9.33 4.59 4.53 2.52 1.93 1.91
Enterprise Value to Operating Cash Flow (EV/OCF)
5.85 7.73 4.65 3.86 5.13 2.50 1.46 1.62 1.09 1.59 2.69
Enterprise Value to Free Cash Flow (EV/FCFF)
13.42 18.19 7.68 5.59 6.76 2.95 1.57 1.72 1.35 2.02 2.77
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.46 0.46 0.45 0.45 0.45 0.46 0.46 0.47 0.48 0.50 0.65
Long-Term Debt to Equity
0.46 0.46 0.45 0.45 0.45 0.46 0.46 0.47 0.48 0.50 0.65
Financial Leverage
-0.26 -0.34 -0.32 -0.25 -0.21 -0.19 -0.04 0.12 0.12 0.21 0.51
Leverage Ratio
2.50 2.43 2.48 2.46 2.47 2.47 2.62 2.73 2.77 2.95 3.26
Compound Leverage Factor
0.97 1.38 2.05 1.96 2.05 5.15 2.25 2.28 2.11 2.35 2.88
Debt to Total Capital
31.71% 31.34% 31.01% 31.10% 31.04% 31.65% 31.72% 32.00% 32.40% 33.14% 39.46%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
31.71% 31.34% 31.01% 31.10% 31.04% 31.65% 31.72% 32.00% 32.40% 33.14% 39.46%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
68.29% 68.66% 68.99% 68.90% 68.96% 68.35% 68.28% 68.00% 67.60% 66.86% 60.54%
Debt to EBITDA
2.77 2.34 2.71 2.45 2.22 2.17 1.53 1.22 0.96 0.63 0.70
Net Debt to EBITDA
-1.44 -1.67 -2.13 -1.64 -1.41 -1.69 -0.92 -0.52 -0.27 -0.01 0.26
Long-Term Debt to EBITDA
2.77 2.34 2.71 2.45 2.22 2.17 1.53 1.22 0.96 0.63 0.70
Debt to NOPAT
5.64 4.48 5.38 4.41 3.68 3.58 2.39 1.82 1.39 0.89 0.98
Net Debt to NOPAT
-2.93 -3.20 -4.22 -2.95 -2.35 -2.78 -1.44 -0.78 -0.40 -0.02 0.36
Long-Term Debt to NOPAT
5.64 4.48 5.38 4.41 3.68 3.58 2.39 1.82 1.39 0.89 0.98
Altman Z-Score
3.30 3.61 3.58 3.61 3.84 3.82 3.72 4.01 4.16 4.62 4.58
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.16 4.85 4.58 4.88 4.71 5.13 4.37 4.65 4.88 5.11 4.24
Quick Ratio
2.58 3.13 3.12 3.22 3.09 3.43 2.86 2.91 2.96 2.61 2.16
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-9.24 -20 49 60 82 196 266 291 206 26 -48
Operating Cash Flow to CapEx
-571.61% 92.70% 838.76% 567.67% -585.24% 897.83% 1,604.76% 1,298.64% 991.70% 935.43% 1,180.51%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 17.80 0.00 0.00 0.00 26.79 0.00 -4.60
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 -6.73 0.00 0.00 0.00 11.57 0.00 13.65
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -7.88 0.00 0.00 0.00 10.41 0.00 12.50
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.82 1.90 1.85 1.92 1.97 2.07 2.10 2.30 2.58 3.17 3.34
Accounts Receivable Turnover
10.41 13.00 10.27 10.63 10.44 13.07 9.94 9.83 9.91 15.06 12.97
Inventory Turnover
6.39 7.04 6.98 6.81 6.52 6.30 6.03 6.09 6.73 7.44 7.61
Fixed Asset Turnover
11.59 12.42 13.09 13.63 13.96 14.53 16.19 18.10 20.45 0.00 0.00
Accounts Payable Turnover
12.80 15.01 12.66 13.58 14.59 16.86 13.21 13.56 16.07 21.82 17.68
Days Sales Outstanding (DSO)
35.05 28.08 35.56 34.35 34.96 27.93 36.71 37.15 36.81 24.24 28.14
Days Inventory Outstanding (DIO)
57.09 51.83 52.28 53.59 55.98 57.91 60.58 59.96 54.24 49.08 47.96
Days Payable Outstanding (DPO)
28.52 24.31 28.82 26.87 25.02 21.65 27.62 26.92 22.72 16.73 20.65
Cash Conversion Cycle (CCC)
63.63 55.59 59.01 61.07 65.92 64.18 69.67 70.19 68.33 56.59 55.46
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
482 436 424 455 466 406 455 498 527 584 692
Invested Capital Turnover
6.19 7.01 6.72 6.33 6.17 6.34 5.71 5.61 6.38 7.72 7.21
Increase / (Decrease) in Invested Capital
17 30 -31 -42 -61 -177 -237 -261 -182 14 115
Enterprise Value (EV)
482 659 660 609 955 765 563 727 532 636 711
Market Capitalization
635 869 891 806 1,142 993 739 852 616 643 576
Book Value per Share
$76.69 $77.13 $76.90 $75.31 $75.41 $72.35 $70.14 $68.52 $67.42 $65.30 $60.08
Tangible Book Value per Share
$66.89 $67.32 $67.14 $65.60 $65.59 $62.52 $60.46 $58.81 $57.57 $55.30 $53.71
Total Capital
932 942 950 947 947 928 925 916 904 882 921
Total Debt
295 295 295 294 294 294 293 293 293 292 363
Total Long-Term Debt
295 295 295 294 294 294 293 293 293 292 363
Net Debt
-154 -211 -232 -197 -187 -228 -176 -125 -83 -6.52 134
Capital Expenditures (CapEx)
5.93 20 7.36 6.31 5.32 8.42 4.84 4.94 8.97 16 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)
437 395 397 430 442 380 433 474 509 567 656
Debt-free Net Working Capital (DFNWC)
886 900 924 921 924 902 903 893 885 866 885
Net Working Capital (NWC)
886 900 924 921 924 902 903 893 885 866 885
Net Nonoperating Expense (NNE)
4.45 3.83 1.77 3.61 3.51 37 4.49 5.25 6.09 8.18 7.44
Net Nonoperating Obligations (NNO)
-154 -211 -232 -197 -187 -228 -176 -125 -83 -6.52 134
Total Depreciation and Amortization (D&A)
8.90 8.75 8.88 9.47 8.78 7.63 7.44 7.30 7.06 7.01 6.04
Debt-free, Cash-free Net Working Capital to Revenue
14.88% 13.37% 13.45% 14.25% 14.43% 12.12% 13.25% 13.47% 12.90% 12.75% 14.33%
Debt-free Net Working Capital to Revenue
30.17% 30.49% 31.26% 30.53% 30.13% 28.75% 27.60% 25.34% 22.44% 19.47% 19.34%
Net Working Capital to Revenue
30.17% 30.49% 31.26% 30.53% 30.13% 28.75% 27.60% 25.34% 22.44% 19.47% 19.34%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.33 $0.67 $1.88 $1.65 $2.02 ($1.98) $2.72 $2.70 $1.96 $3.95 $6.44
Adjusted Weighted Average Basic Shares Outstanding
8.02M 8.29M 8.38M 8.53M 8.66M 8.65M 8.77M 9.00M 9.09M 9.06M 9.04M
Adjusted Diluted Earnings per Share
$0.33 $0.67 $1.87 $1.65 $2.00 ($1.96) $2.71 $2.70 $1.94 $4.46 $6.38
Adjusted Weighted Average Diluted Shares Outstanding
8.02M 8.29M 8.38M 8.53M 8.66M 8.65M 8.77M 9.00M 9.09M 9.06M 9.04M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
8.02M 8.29M 8.38M 8.53M 8.66M 8.65M 8.77M 9.00M 9.09M 9.06M 9.04M
Normalized Net Operating Profit after Tax (NOPAT)
7.26 9.11 18 18 21 19 29 30 24 40 67
Normalized NOPAT Margin
1.02% 1.28% 2.38% 2.34% 2.89% 2.67% 3.56% 3.64% 3.00% 4.74% 6.31%
Pre Tax Income Margin
0.58% 0.98% 2.89% 2.48% 3.17% -1.13% 4.13% 3.94% 3.04% 4.80% 7.60%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 5.98 0.00 0.00 0.00 4.15 0.00 8.72
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 4.54 0.00 0.00 0.00 3.11 0.00 6.41
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 4.83 0.00 0.00 0.00 2.99 0.00 7.56
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 3.39 0.00 0.00 0.00 1.94 0.00 5.25
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
156.92% 85.28% 144.00% 118.32% 0.00% 86.81% 29.72% 8.67% 0.00% 22.43% 19.66%

Frequently Asked Questions About BlueLinx's Financials

When does BlueLinx's financial year end?

According to the most recent income statement we have on file, BlueLinx's fiscal year ends in December. Their fiscal year 2024 ended on December 28, 2024.

How has BlueLinx's net income changed over the last 2 years?

BlueLinx's net income appears to be on a downward trend, with a most recent value of $53.12 million in 2024, falling from $296.18 million in 2022. The previous period was $48.54 million in 2023. Check out BlueLinx's forecast to explore projected trends and price targets.

What is BlueLinx's operating income?
BlueLinx's total operating income in 2024 was $87.57 million, based on the following breakdown:
  • Total Gross Profit: $489.14 million
  • Total Operating Expenses: $401.57 million
How has BlueLinx revenue changed over the last 2 years?

Over the last 2 years, BlueLinx's total revenue changed from $4.45 billion in 2022 to $2.95 billion in 2024, a change of -33.7%.

How much debt does BlueLinx have?

BlueLinx's total liabilities were at $931.28 million at the end of 2024, a 3.1% increase from 2023, and a 3.5% increase since 2022.

How much cash does BlueLinx have?

In the past 2 years, BlueLinx's cash and equivalents has ranged from $298.94 million in 2022 to $521.74 million in 2023, and is currently $505.62 million as of their latest financial filing in 2024.

How has BlueLinx's book value per share changed over the last 2 years?

Over the last 2 years, BlueLinx's book value per share changed from 65.30 in 2022 to 77.13 in 2024, a change of 18.1%.



This page (NYSE:BXC) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners